Nathan is co-founder of MedReleaf Australia and has a diverse background including medical cannabis, pharmaceuticals, FMCG, luxury retail, supply chain, wholesale and franchising. For over 10 years, he has been in the pharmaceutical industry and has worked for leaders in the sector including Australian Pharmaceutical Industries (API), the largest diversified wholesaler and franchisor of pharmaceutical products in Australia. He has a firm foundation of knowledge of the PBS, private and generic medicine marketplace in Australia. Nathan is also involved with MCIA and is a member of several industry working groups for the MCIA.